|
1
|
Cunningham FG, Leveno KJ, Bloom SL, Spong
CY, Dashe JS, Hoffman BL, Casey BM and Sheffield JS: Abortion. In:
William's obstetrics. 24th Edition. McGraw-Hill Education, New
York, NY, p350-376, 2014.
|
|
2
|
Shobeiri SS, Rahmani Z, Hossein Nataj H,
Ranjbaran H, Mohammadi M and Abediankenari S: Uterine natural
killer cell and human leukocyte antigen-G1 and Human Leukocyte
Antigen-G5 expression in vaginal discharge of threatened-abortion
women: A case-control study. J Immunol Res.
2015(692198)2015.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Abbas A, Tripathi P, Naik S and Agrawal S:
‘Analysis of human leukocyte antigen (HLA)-G polymorphism in normal
women and in women with recurrent spontaneous abortions,’. Eur J
Immunogenet. 31:275–278. 2004.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Kanmaz AG, İnan AH, Beyan E and Budak A:
The effects of threatened abortions on pregnancy outcomes. Ginekol
Pol. 90:195–200. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Szabó I and Szilágyi A: Management of
threatened abortion. Early pregnancy. 2:233–240. 1996.PubMed/NCBI
|
|
6
|
Liao Z, Zhou Y, Li H, Wang C, Chen D and
Liu J: The rates and medical necessity of cesarean delivery in the
era of the two-child policy in hubei and gansu provinces, China. Am
J Public Health. 109:476–482. 2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Greene MF: Progesterone for threatened
abortion. N Engl J Med. 380:1867–1868. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Colvin M, McGuire W and Fowlie PW:
Neurodevelopmental outcomes after preterm birth. BMJ.
329:1390–1393. 2004.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Faye-Petersen OM: The placenta in preterm
birth. J Clin Pathol. 61:1261–1275. 2008.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Giakoumelou S, Wheelhouse N, Cuschieri K,
Entrican G, Howie SE and Horne AW: The role of infection in
miscarriage. Hum Reprod Upddate. 22:116–133. 2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Ke RW: Endocrine basis for recurrent
pregnancy loss. Obstet Gynecol Clin North Am. 41:103–112.
2014.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Kaiser J and Branch DW: Recurrent
pregnancy loss: Generally accepted causes and their management.
Clin Obstet Gynecol. 5:464–473. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Qi H, Xuan ZL, Du Y, Cai LR, Zhang H, Wen
XH, Kong XD, Yang K, Mi Y, Fu XX, et al: High resolution global
chromosomal aberrations from spontaneous miscarriages revealed by
low coverage whole genome sequencing. Eur J Obstet Gynecol Reprod
Biol. 224:21–28. 2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Li TC, Makris M, Tomsu M, Tuckerman E and
Laird S: Recurrent miscarriage etiology, management and prognosis.
Hum Reprod Update. 8:463–481. 2002.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Weiss JL, Malone FD, Vidaver J, Ball RH,
Nyberg DA, Comstock CH, Hankins GD, Berkowitz RL, Gross SJ, Dugoff
L, et al: Threatened abortion: A risk factor for poor pregnancy
outcome, a population-based screening study. Am J Obstet Gynecol.
190:745–750. 2004.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Andersen LB, Dechend R, Karumanchi SA,
Nielsen J, Joergensen JS, Jensen TK and Christesen HT: Early
pregnancy angiogenic markers and spontaneous abortion: An Odense
Child Cohort study. Am J Obstet Gynecol. 215:594.e1–594.e11.
2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Su MT, Tsai PY, Tsai HL, Chen YC and Kuo
PL: miR-346 and miR-582-3p-regulated EG-VEGF expression and
trophoblast invasion via matrix metalloproteinases 2 and 9.
Biofactors. 43:210–219. 2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Chau K, Hennessy A and Makris A: Placental
growth factor and pre-eclampsia. J Hum Hypertens. 31:782–786.
2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Babischkin JS, Aberdeen GW, Lindner JR,
Bonagura TW, Pepe GJ and Albrecht ED: Vascular endothelial growth
factor delivery to placental basal plate promotes uterine artery
remodeling in the primate. Endocrinology. 160:1492–1505.
2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Morita A, Nakahara T, Abe N, Kurauchi Y,
Mori A, Sakamoto K, Nagamitsu T and Ishii K: Treatment of
mid-pregnant mice with KRN633, an inhibitor of vascular endothelial
growth factor receptor tyrosine kinase, induces abnormal retinal
vascular patterning in their newborn pups. Birth Defects Res B Dev
Reprod Toxicol. 101:293–299. 2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Patel D and Yulia A: Placental growth
factor testing for pre-eclampsia. Case Rep Womens Health.
33(e00387)2022.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Zhou J, Huang Z, Pan X, Leung WT, Li C,
Chen L, Zhang Y, Wang L, Sima Y, Zhang N, et al: New thoughts in
exploring the pathogenesis, diagnosis, and treatment of threatened
abortion. Biosci Trends. 13:284–285. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Xu L, Wei Q, Wu Q, Zhong Y, Li Y, Xu J and
Zhu Y: Higher β-human chorionic gonadotropin and estrogen levels
during the first 6 weeks of pregnancy are associated with
threatened abortion. Biosci Trends. 13:245–252. 2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Kumari P and Wanjari S: Comparison of
transvaginal colour doppler ultrasound and progesterone level
estimation in outcome of threatened abortion in early pregnancy. J
Clin of Diagn Res. 14:QC11–QC15. 2020.
|
|
25
|
Eskicioglu F, Ozbilgin K, Taskend S, Onal
T and Gokmen T: The role of angiogenic factors in first trimester
pregnancy losses. Clin Exp Obstet Gynecol. 44:566–571. 2017.
|
|
26
|
Muttukrishna S, Swer M, Suri S, Jamil A,
Calleja-Agius J, Gangooly S, Ludlow H, Jurkovic D and Jauniaux E:
Soluble Flt-1 and PlGF: New markers of early pregnancy loss? PLoS
One. 6(e18041)2011.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Dev S, Singh A, Banerjee B, Radhakrishnan
G and Agarwal R: Assessment of maternal serum levels of vascular
endothelial growth factor and placental growth factor in threatened
abortion: A case control study. J Clin of Diagn Res. 14:QC16–QC18.
2020.
|
|
28
|
Hussein S, Ju W, Pizzella S, Flory M, Chu
C, Wang Y and Zhong N: Reduced expression in preterm birth of
sFLT-1 and PlGF with a high sFLT-1/PlGF ratio in extracellular
vesicles suggests a potential biomarker. Front Endocrinol
(Lausanne). 13(1024587)2022.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Keskin U, Ulubay M, Dede M, Ozgurtas T,
Koçyiğit YK, Aydin FN and Ergün A: The relationship between the
VEGF/sVEGFR-1 ratio and threatened abortion. Arch Gynecol Obstet.
291:557–561. 2015.PubMed/NCBI View Article : Google Scholar
|
